Abstract
Autophagy is a lysosome-dependent degradation program to maintain cellular homeostasis in response to a variety of stressful conditions, such as long-lived or non-functional subcellular organelles, protein aggregates, nutrient limitation, and virus/bacteria infection. Accordingly, dysregulation of autophagy is closely associated with many human pathophysiological conditions, such as neurodegenerative diseases, aging, and cancer, and autophagy is highlighted as an important therapeutic target for these human diseases. In autophagy process, PIK3C3/VPS34 complex plays important roles in autophagosome biogenesis. Accumulating evidences that inhibition of PIK3C3/VPS34 complex successfully blocks autophagy make the complex as an attractive target for the development of autophagy-specific inhibitors. However, considering that various forms of PIK3C3/VPS34 complex exist and they are involved in many different cellular functions, the targeting of the pro-autophagy PIK3C3/VPS34 complex is required to specifically inhibit autophagy. To identify autophagy inhibitors targeting the pro-autophagy complex, we have performed the screening of a customized natural product library consisting of 35 herbal extracts which are widely used in the oriental medicine as anti-inflammation and/or anti-tumor reagents. We discovered that an alcoholic extract of Thuja orientalis L. leaves inhibits pro-autophagy complex formation by disrupting the interaction between autophagy-specific factor, ATG14L, and the complex core unit Vps34-Beclin 1 in vitro. Also, it inhibits the nutrient starvation induced autophagy and diminished pro-autophagy PIK3C3/VPS34 complex containing either ATG14L or UVRAG in several cell lines. Our results strongly suggest that Thuja orientalis L. leave extract functions as an autophagy-specific inhibitor not decreasing the complex activity nor the protein level, but preventing protein–protein interaction between autophagy-specific factor (ATG14L and UVRAG) and PIK3C3/VPS34 complex core unit, Vps34-Beclin 1, thereby specifically depleting the pro-autophagy complex to inhibit autophagy.
Similar content being viewed by others
Introduction
Macroautophagy (referred to as autophagy hereafter) is a lysosome-dependent catabolic pathway to remove dysfunctional, unnecessary, or harmful intracellular contents, such as long-lived/damaged subcellular organelles and protein aggregates, and infected pathogens, via a double-membrane vesicle, an autophagosome1,2,3. As an essential cellular homeostasis program, dysfunction of autophagy is closely associated with various pathophysiological conditions, including metabolic disorders, neurodegenerative diseases, aging, cardiomyopathy, and cancers1,4,5. In this sense, autophagy is believed to provide a new avenue to control human diseases5,6,7,8. Although autophagy has been studied by various pharmacological approaches, however, the development of autophagy-specific modulator has just begun. Most popular way for autophagy inhibition relies on the regulation of lysosomal activity9. Typically, Chloroquine (CQ) prevents the fusion of autophagosome with lysosome by raising lysosomal pH. However, as a lysosomotropic agent, CQ also blocks fusion of endosomes with lysosome in endocytosis10. 3-methyladenine (3-MA), and wortmannin are another examples of autophagy inhibitors11,12. They target the autophagy-initiating PIK3C3/VPS34 lipid kinase complex to block the production of phosphatidylinositol 3-phosphate (PI3P) on the initiating autophagosome membrane 13,14 to recruit the autophagy machinery required for autophagosome biogenesis3,15. However, as a broad-spectrum inhibitor of all PI3-kinase (PIK3) family members, they also diminish PIK3C1-AKT/PKB signaling pathway that may activate autophagy by inhibiting mTORC1, a well-known negative upstream regulator of autophagy. Moreover, considering that PIK3C1-AKT/PKB signaling is involved in various cellular processes16,17, ranging from metabolism to apoptosis, the use of 3-MA and wortmannin as autophagy inhibitors is limited. However, the observation that they successfully inhibit autophagy, although not specific, suggests that PIK3C3/VPS34 complex is a potent target for autophagy-specific inhibitors. Much efforts have been made to develop autophagy inhibitors targeting PIK3C3/VPS34 complex and several small molecules have identified to inhibit the complex activity, and concomitantly, autophagy18,19,20,21. However, it should be noted that PIK3C3/VPS34 complex exists in various forms and contribute a number of cellular functions, such as multivesicular body pathway, retrograde trafficking from endosomes to the Golgi, phagosome maturation, and autophagy22,23, depending on the subunits binding to the PIK3C3/VPS34 complex core unit, Vps34-Beclin 1. Therefore, considering of PIK3C3/VPS34 complex core unit, Vps34-Beclin1, as a platform for the various complexes with multiple functions, the inhibitors directly targeting the subunits of the complex core unit, Vps34 lipid kinase (SAR40518, PIK-III19, and Vps34-IN120) or Beclin 1 (Spautin-121), may switch off all PIK3C3/VPS34 complex functions, including autophagy. Among the complex family, PIK3C3/VPS34 complex containing either ATG14L or UVRAG functions as pro-autophagy complex24,25 and are activated upon autophagy-inducing condition, but not the others26,27,28. These results indicate that binding of the autophagy-specific factors, such as ATG14L or UVRAG, to the complex core unit, Vps34-Beclin 1, makes the resulting complex to pro-autophagy complex, therefore, the inhibition of protein–protein interaction (PPI) between these autophagy-specific factors and Beclin 1 on the complex core unit will specifically inhibit autophagy without affecting other PIK3C3/VPS34 complexes and their functions. In this aspect, we previously developed in vitro Vps34-Beclin 1-ATG14L formation assay to monitor ATG14L binding to the complex core unit, Vsp34-Beclin 129. Using the in vitro assay format, we have screened a customized library consisting of 35 natural herbal extracts, which have been widely used as anti-inflammatory, anti-tumor, or anti-bacterial/viral agents in oriental medicine. As a result, an alcoholic extract of Thuja orientalis L. leaves was identified to inhibit Vps34-Beclin 1-ATG14L complex formation in vitro. In addition, it potently inhibits the nutrient starvation-induced autophagy in various cells, in which it specifically diminished the pro-autophagy PIK3C3/VPS34 complex by disrupting ATG14L (or UVRAG) binding to the complex core unit, Vps34-Beclin 1.
Results
A screening of natural herbal medicinal extracts disrupting pro-autophagy PIK3C3/VPS34 complex by inhibiting ATG14L binding to the complex core unit, Vps34-Beclin 1
Although the underlying mechanism is still largely unknown, accumulating reports have shown that the medicinal effects of various natural herbal extracts used in oriental medicine are dependent on autophagy30. It makes the natural herbal medicinal extracts as an attractive repertoire for developing autophagy-specific modulators. Especially, considering the complexity of protein–protein binding interface, the natural extract may be a good starting resource to obtain PPI inhibitor to prevent ATG14L from binding to PIK3C3/VPS34 complex core unit, because a single small molecule may not good enough to interfere with PPI. For the inhibitor screening, we have selected 35 natural herbal medicinal extracts (E1-E35, Table 1), which are mostly used as anti-inflammatory, anti-tumor, or anti-bacterial/viral agents in oriental medicine, to make up the screening library. Considering the significance of autophagy in immune responses, these natural herbal extracts are expected to have a role in autophagy. In the inhibitor screening, the purified ATG14L protein was added into the immobilized PIK3C3/VPS34 complex core unit, Vps34-Beclin 1, to reconstitute pro-autophagy complex, Vps34-Beclin 1-ATG14L, in which natural herbal extract was added to examine the complex formation by ELISA against ATG14L and Beclin 1, respectively (Fig. 1a). When the extract specifically interferes with PPI between ATG14L and Beclin 1, ELISA signal for ATG14L will be decreased, but the Beclin 1 signal will not change. Therefore, the ratio of Beclin 1/ATG14L ELISA value will be increased. In the initial screening shown in Fig. 1b, ten natural extracts (E4, E8, E10, E12, E19, E21, E22, E29, E33, and E34) showed neither Beclin 1 nor ATG14L ELISA signals, suggesting that they might affect the complex core unit Vps34-Beclin 1 on the plate at 0.2 mg/ml concentration. Except them, thirteen extracts caused the decrease in ATG14L signal more than 80% (Fig. 1b), of which the nine extracts have changed Beclin 1 signal less than 50% decrease so that their Beclin 1/ATG14L ELISA signal ratio was greater than 3 (Fig. 1c). For these nine candidates from the first round screening, we have repeated the same experiment with them at fourfold diluted condition (0.05 mg/ml) to obtain more potent inhibitors. As shown in Fig. 2a, E5 (Forsythia koreana Nakai), E6 (Artemisia scoparia Waldst. & Kitam.), E14 (Morus bombycis Koidz.), E17 (Ampelopsis japonica Makino), and E18 (Thuja orientalis L.) still potently inhibited ATG14L binding more than 70%, and they have almost no effect on the complex core unit (less than 10% decrease in Beclin 1). To evaluate the kinetics for the inhibition of ATG14L binding to the complex core unit, Vps34-Beclin 1, the dose-dependent inhibition of ATG14L binding was tested and their inhibition curve was plotted to obtain the maximum inhibition (%) and IC50. As shown in Fig. 2b. All five natural herbal extracts inhibit ATG14L binding at maximum around 80% and their IC50 was in the range from 1 μg/ml (E5) to 13 μg/ml (E18).
An alcoholic extract of T. orientalis L. inhibits the starvation-induced autophagy in cells
Next, we have determined the effect of these five candidate extracts on cellular autophagy responses. The nutrient starvation is long-believed to induce autophagy to maintain cellular energy homeostasis 2. The cells were starved with glucose, a primary energy source in cell culture medium, in which each extract was added. For overnight starvation, almost of all cells were dead in the presence of E5, E14, or E17 at the concentration of 0.2 mg/ml, suggesting their high toxicity in this experimental condition. In contrast, cell viability was little affected by either E6 or E18. As shown in Fig. 3a, glucose starvation induced autophagy as evidenced by the immunoblot showing the increase in LC3-II upon the starvation. In this condition, E6 has no effect on the starvation-induced autophagy, but E18 dramatically decreased the starvation-induced LC3-II, demonstrating that E18, an alcoholic extract of Thuja orientalis L. leaves (hereafter referred to as T. orientalis), functions as an inhibitor of autophagy in response to the starvation. Notably, under T. orientalis, both LC3-II in the absence or presence of a lysosome blocker, NH4Cl, was much lower than the control. NH4Cl suppresses autophagy flux to block LC3-II degradation in autolysosome, thereby accumulating LC3-II, but it was significantly suppressed by T. orientalis. Similarly, the inhibition of the basal autophagy flux by another lysosomal inhibitor, Chloroquine (CQ), was also significantly decreased by T. orientalis (Fig. 3b). These results collectively suggest that T. orientalis functions as an autophagy inhibitor in a manner different to the lysosome blockers and its inhibition may occur before lysosomal degradation, probably, at the initiation step regulated by PIK3C3/VPS34 complex as it was discovered as an inhibitor of PIK3C3/VPS34 complex formation in vitro. Therefore, T. orientalis is expected to decrease autophagy flux, but not block the flux. Inhibition of T. orientalis on the starvation-induced autophagy was increased in a dose-dependent manner (Fig. 3c). Also, the inhibition of the starvation-induced autophagy was observed in several other cell lines, such as HEK293, NIH3T3, and human cancer cell line, HCT116 (Fig. 3d), suggesting that it may function as a general autophagy inhibitor at least upon the nutrient starvation. Next, we have tried to identify an active single component in T. orientalis required for the autophagy inhibition. In search of the literature analyzing the components of T. orientalis31,32, we have found that it was made up of more than 20 components, of which top five components more than 5% in the extract total were chosen31: α-pinene (~ 29%), Δ-3-carene (~ 20%), α-cedrol (~ 10%), β-caryophyllene (~ 8%), and α-humulene (~ 6%). We have treated these single components at the maximum concentration at which the cells were viable at least more than 50% in overnight treatment and examined their inhibition potency against the starvation-induced autophagy (Fig. 4a). Unfortunately, under the overnight starvation, although there were variations in cell viability, none of any single component was as effective as T. orientalis in the inhibition of the starvation-induced autophagy. In addition, top three components (pinene, carene, and cedrol) were mixed together to test their efficacy of autophagy inhibition, this mixture barely inhibited the starvation-induced autophagy (Fig. 4b). It suggests that inhibition effect of T. orientalis on the starvation-induced autophagy may rely on either the other component present in the smaller amount in the extract or the more complex combination of the extract components.
T. orientalis specifically decreases pro-autophagy PIK3C3/VPS34 complex containing ATG14L (or UVRAG) in cells
Finally, to examine inhibition mechanism of T. orientalis on autophagy, we have analyzed pro-autophagy PIK3C3/VPS34 complex in cells because it was originally identified as an inhibitor targeting the formation of pro-autophagy complex, Vps34-Beclin 1-ATG14L, in vitro. To this end, the plasmids encoding HA-Vps34, Flag-Beclin 1, and HA-ATG14L, respectively, were transfected to HEK293 cells and Flag-Beclin 1 was immunoprecipitated. Co-immunoprecipitations (Co-IPs) of HA-Vps34 and HA-ATG14L were tested for their binding to Beclin 1 by their immunoblots. As shown in Fig. 5a, both HA-Vps34 and HA-ATG14L were co-immunoprecipitated by Flag-Beclin1 in control, indicating the formation of pro-autophagy Vps34-Beclin 1-ATG14L complex in this experimental setting. However, in the presence of T. orientalis, Co-IP of ATG14L was significantly decreased in the Beclin 1 immune-complex, whereas Co-IP of Vps34 was not affected. To further confirm that T. orientalis specifically inhibits Beclin 1-ATG14L binding, we carried out two different endogenous Vps34 and ATG14L Co-IP assay. First, we have transfected Flag-Beclin1 into HEK293 cells and then Co-IPs of the endogenous Vps34 and ATG14L in Flag-Beclin 1 immune-complex was examined by immunoblots (Fig. 5b). Consistent with the transfection result in Fig. 5a, almost the same amount of the endogenous Vps34 was co-immunoprecipitated regardless of T. orientalis, but Co-IP of ATG14L was significantly decreased in T. orientalis treatment condition. Second, we have conducted Co-IP assay targeting the endogenous Beclin 1 in both MEFs and HEK293. Consistently, we obtained the same Co-IP results for the endogenous Vps34 and ATG14L in the endogenous Beclin 1 immune-complex from MEFs (Fig. 5c), in which only Co-IP of the endogenous ATG14L was decreased by T. orientalis. We did not obtain a reliable Co-IP result for ATG14L in the endogenous Beclin 1 immune-complex from HEK293, but we have obtained very clear Co-IP of the endogenous UVRAG in this cell (Fig. 5d). Like as ATG14L, Co-IP of the endogenous UVRAG was dramatically decreased upon T. orientalis, but Co-IP of the endogenous Vps34 was not. Considering that ATG14L and UVRAG compete with Beclin 1 binding and their binding regions on Beclin 1 are closely overlapped, it is expected that T. orientalis can disrupt both ATG14L and UVRAG containing PIK3C3/VPS34 complex. These results collectively support that T. orientalis specifically target pro-autophagy PIK3C3/VPS34 complex containing either ATG14L or UVRAG by disrupting these autophagy-specific subunit binding to Beclin 1, but not the interaction of the complex core unit, Vps34-Beclin 1, as proposed in in vitro complex formation screening.
Discussion
In this study, we have identified an alcoholic extract of T. orientalis L. leaves as an autophagy-specific inhibitor by targeting pro-autophagy PIK3C3/VPS34 complex containing either ATG14L or UVRAG. We have screened a customized natural product library consisting of 35 herbal medicinal extracts with anti-inflammation, anti-tumor, or anti-bacterial/viral activities, which are closely related to pathophysiological roles of autophagy. An in vitro pro-autophagy Vps34-Beclin 1-ATG14L complex formation assay was carried out in the presence of each natural herbal extract and then, the selected hit extracts were tested their autophagy inhibition activities in cells. Among 35 extracts, T. orientalis successfully inhibited the starvation-induced autophagy and specifically disrupt pro-autophagy PIK3C3/VPS34 complex formation in both in vitro and cells. It specifically targets Beclin 1-ATG14 (or UVRAG) binding, but not the complex core unit, Vps34-Beclin 1, binding. These results indicate that T. orientalis could be an autophagy inhibitor specifically disrupting the pro-autophagy PIK3C3/VPS34 complex by preventing autophagy-specific factors, ATG14L or UVRAG, from the binding to the complex core unit, Vps34-Beclin 1. It is important because the complex core unit Vps34-Beclin 1 is a backbone of the complex, in which Beclin 1 recruits many different subunits as a scaffold subunit to form various PIK3C3/VPS34 complexes in a wide spectrum of cell physiology, such as vesicle trafficking, endocytosis, and amino acid signaling23. Therefore, a targeting a pro-autophagy PIK3C3/VPS34 complex by T. orientalis may result in the regulation of one specific function of various PIK3C3/VPS34 complexes, autophagy, but not the other functions. In this sense, it is different to other PIK3C3/VPS34 inhibitors, such as 3-MA and Spautin-1, both of which target the complex core unit. 3-MA is a catalytic inhibitor of Vps3411 and Spautin-1 targets Beclin 1 degradation21, thereby they may affect all PIK3C3/VPS34 complex family members. It should be noted that T. orientalis disrupts both ATG14L- and UVRAG-containing pro-autophagy PIK3C3/VPS34 complex. ATG14L and UVRAG participate in the complex by binding to Beclin 1 in a mutually exclusive manner, suggesting that their binding sites on Beclin 1 are overlapped. Therefore, although T. orientalis was initially identified to disrupt Beclin 1-ATG14L binding by an in vitro Vps34-Beclin 1-ATG14L complex formation assay, it is expected that it also affects the UVRAG-containing complex. Indeed, it was observed that T. orientalis diminished both ATG14L- and UVRAG-containing PIK3C3/VPS34 complex in MEFs or HEK293 cells to inhibit autophagy. Importantly, UVRAG-containing PIK3C3/VPS34 complex is known to play an important role in the maturation of autophagosome as well as endosomal trafficking, whereas ATG14L-containing one is believed to mainly function in the initiation of autophagosome formation33,34. Therefore, the fact that T. orientalis also disrupt Vps34-Beclin 1-UVRAG complex may result in its undesirable effects in endolysosomal pathway. Notably, the treatment of T. orientalis appears to slightly decrease the protein level of ATG14L (Fig. 5a,b), therefore, it is possible that the reduction of Vps34-Beclin 1-ATG14L complex in this condition may result from the decrease in ATG14L protein level, but not the inhibition of Beclin 1-ATG14L binding. However, it is also possible that free ATG14L that do not participate in the complex by T. orientalis is unstable to be degraded, decreasing the protein level. One more caution to use T. orientalis as an autophagy inhibitor is that it may not work in PIK3C3/VPS34 independent (or bypass) autophagy. Also, if there is any mutation in Beclin1-ATG14L (or UVRAG) binding interface or surrounding regions, this protein–protein interaction inhibitor may be no longer functional in the pro-autophagy PIK3C3/VPS34 complex containing them, thereby no effect on autophagy. Unfortunately, we could not assign a single active component in the extract of T. orientalis for autophagy inhibition. It may cause some trouble in developing it as a drug, but the extract of T. orientalis has been long and extensively used in the oriental medicine, therefore, it will provide an important clue to develop an autophagy-specific inhibitor as a therapeutic reagent for human diseases.
Methods
Materials
Antibodies used in this study are as follows: anti-Vps34 (Cell signaling, #4263), anti-Beclin1 (Cell signaling, #3738; Santa Cruz, sc-48341 for immunoprecipitation), anti-ATG14L (MBL, PD016), anti-UVRAG (Cell signaling, #13115), LC3B (Cell signaling, #2775), α-tubulin (Santa Cruz, sc-23948), anti-vinculin (SIGMA, V9131) anti-Flag HRP conjugate (Sigma, A8592), anti-HA HRP conjugate (Cell signaling, #2999S) and the secondary antibodies conjugated with HRP, anti-Rabbit IgG-HRP (Bethyl, #A120-101P) and anti-Mouse IgG-HRP (Bethyl, #A90-116P). The affinity resins for the protein purification or immunoprecipitation were obtained from SIGMA (Flag-M2 agarose, A2426), GE Healthcare (GSH-Sepharose, 17-0756-01; Protein G-Sepharose, 17-0618-01), and Invitrogen (Protein A-Sepharose, #101041). Chloroquine (C6628), α-pinene (147524), Δ-3-carene (115576), α-cedrol (93483), β-caryophyllene (22075), and α-humulene (5375) were obtained from Sigma-Aldrich. High glucose (25 mM) DMEM (LM-001-07) and glucose-free DMEM (LM001-56) were from Welgene.
In vitro Vps34-Beclin 1-ATG14L complex formation assay for natural herbal extract library screening
A detailed protocol to prepare the in vitro Vps34-Beclin 1-ATG14L complex formation assay in high-throughput format can be found in our previous reports29. Briefly, N-terminally tagged GST-Vps34, Flag-Beclin 1, and Flag-ATG14L were prepared from the transfected HEK293 cells. To reconstitute Vps34-Beclin 1-ATG14L pro-autophagy complex on the microwell plate, purified GST-Vps34 protein was firstly added and bound to glutathione (GSH)-coated 96 well plate and then the Flag-Beclin1 protein and Flag-ATG14L were sequentially added to reconstitute the complex with a defined orientation. Unbound proteins were extensively washed with TBS (10 mM Tris, pH8.0, and 150 mM NaCl) containing 0.5% Tween-20 (TBS-T5). For library screening, each natural herbal medicinal extract was diluted in PBS as indicated, and added to the microwell containing the Vps34-Beclin 1-ATG14L complex in 100 μl volume. After 30 min incubation at room temperature, the extracts were removed and the microwells were extensively washed with TBS-T5. The remaining Flag-Beclin 1 and Flag-ATG14L protein was determined by ELISA against anti-Beclin 1 antibody (1:100 dilution in TBS containing 0.05% Tween-20, TBST) and anti-ATG14L antibody (1:500 in TBST), respectively.
Cell culture and transfection
HEK293 (ATCC, CRL-1573), NIH3T3 (Korean Cell Line Bank, #21,658), and mouse embryonic fibroblasts (MEFs, a gift from Dr. Kun-Liang Guan, Dept. of Pharmacology, Univ. of California San Diego, La Jolla, CA, USA) cells were cultured in high glucose (25 mM) DMEM medium containing 10% fetal bovine serum (FBS; Invitrogen) and 50 μg/ml penicillin/streptomycin. For HCT116 human colon cancer cell line (ATCC, CCL-247), cells were grown in RPMI-1640 (Welgene) containing the same serum and antibiotics mixture. To express pro-autophagy PIK3C3/VPS34 complex in cells, the mammalian expression plasmids encoding Vps34, Beclin 1, and ATG14L, respectively, with appropriate N-terminal tags were transfected into HEK293 cells by polyethylenimine (PEI, SIGMA) method as previously reported35. After 2 day incubation, the transfected HEK293 cells were washed with ice-cold PBS and lysed in Mild Lysis Buffer (MLB, 10 mM Tris, pH7.5, 2 mM EDTA, 100 mM NaCl, 1% NP-40, 50 mM NaF, 1 mM Na3VO4, and protease inhibitor cocktail) to harvest the total cell lysates for protein purification, immunoblots and immunoprecipitation. Also, the total cell lysates for endogenous protein analysis was also obtained with MLB as above.
Preparation of alcoholic extracts of T. orientalis L. leaves
The commercially available air-dried T. orientalis L. leaves were purchased from the Korean traditional medicine market (Seoul Yangnyeong market). A detailed preparation procedure is demonstrated in elsewhere32. Briefly, the dried leaves of T. orientalis L. have been extracted in 70% ethanol with stirring for 24 h at room temperature. The resulting alcoholic extract was filtrated, concentrated in a rotary vacuum evaporator under the heating at 50 °C, and finally lyophilized to the powder. The powder was dissolved in DMSO and kept on − 20 °C.
Immunoblotting and immunoprecipitation
Protein samples were resolved on SDS/PAGE and then, electrophoretically transferred onto a PVDF membrane. The membranes were blocked with TBST buffer containing 5% skim milk at room temperature for 1 h. The membranes were incubated with a primary antibody against the indicated proteins, which is diluted in TBST buffer containing 1% BSA to 1:1000 at 4 °C overnight, followed by the reaction with HRP-conjugated secondary antibodies at room temperature for additional 1 h. Antibody detection was carried out using ECL detection kit (PIERCE). For immunoprecipitation, 0.5–1 mg of total cell lysates reacts with the antibody-coupled bead complex, which was prepared by incubation of a specific target antibody with protein A (or G)-coupled Agarose in TBST containing 5% BSA at 4 °C overnight. The immunoprecipitation reaction was carried out at 4 °C for 3–5 h with a gentle rocking. Unbound proteins were removed by an extensive washing with MLB and the immune-complex was analyzed by immunoblots against the antibody recognizing the protein of interest.
References
Yang, Y. & Klionsky, D. J. Autophagy and disease: Unanswered questions. Cell Death Differ. 27, 858–871. https://doi.org/10.1038/s41418-019-0480-9 (2020).
Chun, Y. & Kim, J. Autophagy: An essential degradation program for cellular homeostasis and life. Cells https://doi.org/10.3390/cells7120278 (2018).
Walker, S. A. & Ktistakis, N. T. Autophagosome biogenesis machinery. J. Mol. Biol. 432, 2449–2461. https://doi.org/10.1016/j.jmb.2019.10.027 (2020).
Levine, B. & Kroemer, G. Biological functions of autophagy genes: A disease perspective. Cell 176, 11–42. https://doi.org/10.1016/j.cell.2018.09.048 (2019).
Choi, A. M., Ryter, S. W. & Levine, B. Autophagy in human health and disease. N. Engl. J. Med. 368, 1845–1846. https://doi.org/10.1056/NEJMc1303158 (2013).
Wu, L. & Yan, B. Discovery of small molecules that target autophagy for cancer treatment. Curr. Med. Chem. 18, 1866–1873. https://doi.org/10.2174/092986711795496773 (2011).
Baek, K. H., Park, J. & Shin, I. Autophagy-regulating small molecules and their therapeutic applications. Chem. Soc. Rev. 41, 3245–3263. https://doi.org/10.1039/c2cs15328a (2012).
Morel, E. et al. Autophagy: A druggable process. Annu. Rev. Pharmacol. Toxicol. 57, 375–398. https://doi.org/10.1146/annurev-pharmtox-010716-104936 (2017).
Shen, H. M. & Mizushima, N. At the end of the autophagic road: An emerging understanding of lysosomal functions in autophagy. Trends Biochem. Sci. 39, 61–71. https://doi.org/10.1016/j.tibs.2013.12.001 (2014).
Steinman, R. M., Mellman, I. S., Muller, W. A. & Cohn, Z. A. Endocytosis and the recycling of plasma membrane. J. Cell Biol. 96, 1–27. https://doi.org/10.1083/jcb.96.1.1 (1983).
Caro, L. H., Plomp, P. J., Wolvetang, E. J., Kerkhof, C. & Meijer, A. J. 3-Methyladenine, an inhibitor of autophagy, has multiple effects on metabolism. Eur. J. Biochem. 175, 325–329. https://doi.org/10.1111/j.1432-1033.1988.tb14200.x (1988).
Blommaart, E. F., Krause, U., Schellens, J. P., Vreeling-Sindelarova, H. & Meijer, A. J. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 243, 240–246. https://doi.org/10.1111/j.1432-1033.1997.0240a.x (1997).
Reidick, C., Boutouja, F. & Platta, H. W. The class III phosphatidylinositol 3-kinase Vps34 in Saccharomyces cerevisiae. Biol. Chem. 398, 677–685. https://doi.org/10.1515/hsz-2016-0288 (2017).
Ktistakis, N. T., Manifava, M., Schoenfelder, P. & Rotondo, S. How phosphoinositide 3-phosphate controls growth downstream of amino acids and autophagy downstream of amino acid withdrawal. Biochem. Soc. Trans. 40, 37–43. https://doi.org/10.1042/BST20110684 (2012).
Noda, T., Matsunaga, K., Taguchi-Atarashi, N. & Yoshimori, T. Regulation of membrane biogenesis in autophagy via PI3P dynamics. Semin. Cell Dev. Biol. 21, 671–676. https://doi.org/10.1016/j.semcdb.2010.04.002 (2010).
Fruman, D. A. & Rommel, C. PI3K and cancer: Lessons, challenges and opportunities. Nat. Rev. Drug Discov. 13, 140–156. https://doi.org/10.1038/nrd4204 (2014).
Kim, J. & Guan, K. L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63–71. https://doi.org/10.1038/s41556-018-0205-1 (2019).
Ronan, B. et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat. Chem. Biol. 10, 1013–1019. https://doi.org/10.1038/nchembio.1681 (2014).
Dowdle, W. E. et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat. Cell Biol. 16, 1069–1079. https://doi.org/10.1038/ncb3053 (2014).
Honda, A. et al. Potent, selective, and orally bioavailable inhibitors of VPS34 provide chemical tools to modulate autophagy in vivo. ACS Med. Chem. Lett. 7, 72–76. https://doi.org/10.1021/acsmedchemlett.5b00335 (2016).
Liu, J. et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223–234. https://doi.org/10.1016/j.cell.2011.08.037 (2011).
Yan, Y. & Backer, J. M. Regulation of class III (Vps34) PI3Ks. Biochem. Soc. Trans. 35, 239–241. https://doi.org/10.1042/BST0350239 (2007).
Funderburk, S. F., Wang, Q. J. & Yue, Z. The Beclin 1-VPS34 complex–at the crossroads of autophagy and beyond. Trends Cell Biol. 20, 355–362. https://doi.org/10.1016/j.tcb.2010.03.002 (2010).
Sun, Q. et al. Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 105, 19211–19216. https://doi.org/10.1073/pnas.0810452105 (2008).
Liang, C. et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat. Cell Biol. 8, 688–699. https://doi.org/10.1038/ncb1426 (2006).
Yuan, H. X., Russell, R. C. & Guan, K. L. Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy. Autophagy 9, 1983–1995. https://doi.org/10.4161/auto.26058 (2013).
Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741–750. https://doi.org/10.1038/ncb2757 (2013).
Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290–303. https://doi.org/10.1016/j.cell.2012.12.016 (2013).
Kim, T. M., Baek, J. H., Kim, J. H., Oh, M. S. & Kim, J. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening. Anal. Biochem. 480, 21–27. https://doi.org/10.1016/j.ab.2015.04.004 (2015).
Wang, S. F., Wu, M. Y., Cai, C. Z., Li, M. & Lu, J. H. Autophagy modulators from traditional Chinese medicine: Mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. J. Ethnopharmacol. 194, 861–876. https://doi.org/10.1016/j.jep.2016.10.069 (2016).
Guleria, S., Kumar, A. & Tiku, A. K. Chemical composition and fungitoxic activity of essential oil of Thuja orientalis L. grown in the north-western Himalaya. Z. Naturforschung C J. Biosci. 63, 211–214. https://doi.org/10.1515/znc-2008-3-409 (2008).
Ju, M. S. et al. Protective effects of standardized Thuja orientalis leaves against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. Toxicol. In Vitro 24, 759–765. https://doi.org/10.1016/j.tiv.2009.12.026 (2010).
Kihara, A., Noda, T., Ishihara, N. & Ohsumi, Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519–530. https://doi.org/10.1083/jcb.152.3.519 (2001).
Li, X. et al. Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat. Commun. 3, 662. https://doi.org/10.1038/ncomms1648 (2012).
Horbinski, C., Stachowiak, M. K., Higgins, D. & Finnegan, S. G. Polyethyleneimine-mediated transfection of cultured postmitotic neurons from rat sympathetic ganglia and adult human retina. BMC Neurosci. 2, 2. https://doi.org/10.1186/1471-2202-2-2 (2001).
Acknowledgements
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education in Korea (MEST, 2018R1D1A1B07048869) and by a grant from Kyung Hee University in 2018 (KHU-20181068).
Author information
Authors and Affiliations
Contributions
J.J. carried out experiments and analyzed the data. Y.C. organized and analyzed the data as well. Y.P.J. and M.S.O. provided a customized library of 35 natural herbal medicinal extracts. J.H.K. contributed to supervise the experiments and manuscript preparation. J.K. designed experiments, performed some parts of experiments, analyzed the data, and wrote the manuscript. All authors have read and agreed to submit the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jung, J., Chun, Y., Jang, Y.P. et al. An alcoholic extract of Thuja orientalis L. leaves inhibits autophagy by specifically targeting pro-autophagy PIK3C3/VPS34 complex. Sci Rep 11, 17712 (2021). https://doi.org/10.1038/s41598-021-97216-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-97216-4
- Springer Nature Limited
This article is cited by
-
PACAP–Sirtuin3 alleviates cognitive impairment through autophagy in Alzheimer’s disease
Alzheimer's Research & Therapy (2023)
-
Inhibition of autophagy potentiates the cytotoxicity of the irreversible FGFR1-4 inhibitor FIIN-2 on lung adenocarcinoma
Cell Death & Disease (2022)